• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Finland·Healthcare·TTALO.HE
Share

Terveystalo Oyj Stocks

€ 5.96Last Updated 23.10.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

€ 846.72M

€ 5.96
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Excellent dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Terveystalo Oyj, based in Helsinki, Finland, stands as a leading provider of healthcare services, with a strong focus on occupational health for businesses across the country. Its extensive service portfolio covers general practitioner consultations, specialized medical care, diagnostic procedures, outpatient and day surgery, and a full spectrum of dental and oral health services. The company further extends its offerings to include laboratory and imaging capabilities, wellbeing programs, child welfare services, and various healthcare outsourcing and staffing solutions. Terveystalo also provides modern digital healthcare platforms and engages in clinical research. Serving a diverse clientele, its customers range from private individuals and corporate entities to insurance companies and the public sector. The company maintains a substantial physical presence, operating 360 clinics throughout Finland, which include 18 hospital units, 38 dental clinics, and 73 Rela hierojat massage therapy units. Terveystalo Oyj was established in 2001.

Company Valuation

Undervalued
6/7

Based on key historical and expected multiples, the stock is undervalued relative to its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITDA, unde

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of TTALO.HE is 6.86 and suggests 15.1% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

27.10.2026 02:47

Investors' appetite for risk has returned: AI sector stocks started the week on an upswing

27.10.2026 01:51

Anthropic reveals dependence on Google, Amazon, and Microsoft ahead of IPO

27.10.2026 00:38

Microsoft is cutting costs: 60,000 employees have been offered voluntary separation

27.10.2026 00:18

‘It’ll likely start as a credit event’: How neocloud woes threaten the S&P 500

26.10.2026 23:40

Buyers of the foldable iPhone have complained about screen damage. How does this affect the stock price?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026